Establishes safety and care requirements for clinician-administered drugs in New Hampshire.
New Hampshire SB256 amends RSA 420-B to introduce a new section on the dispensing of clinician-administered drugs. This bill defines "clinician-administered drug" as an outpatient prescription drug that cannot be self-administered and is typically administered by a health care professional in a clinical setting. It mandates that health maintenance organizations and third parties cannot require pharmacies to dispense these drugs directly to patients if doing so would delay treatment. The act takes effect January 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.